SimBioSys Secures Third FDA Clearance for TumorSight™ Viz to Advance Precision in Breast Cancer Surgery

SimBioSys®, a clinical AI company leveraging spatial biophysics to drive precision in breast cancer treatment, today announced its third FDA 510(k) c...

July 10, 2025 | Thursday | News
Amarna Therapeutics and NorthX Biologics Advance Gene Therapy Manufacturing for Type 1 Diabetes

Amarna Therapeutics, (“Amarna” or “the Company”), a privately held biotechnology company pioneering transformative gene therapies...

July 09, 2025 | Wednesday | News
Medvantx Acquires RxS to Deliver Unified Pharmacy Access and Multichannel Sample Management Solutions

Medvantx, a leading pharmacy services company, announced that it acquired RxS, a leader in multichannel sample management and accountability solutions. T...

July 09, 2025 | Wednesday | News
Johnson & Johnson Submits EMA Application to Broaden AKEEGA® Use in HRR‑Mutated Metastatic Hormone‑Sensitive Prostate Cancer

The submission is based on results from the Phase 3 AMPLITUDE study evaluating niraparib in combination with abiraterone acetate plus prednisone or predn...

July 07, 2025 | Monday | News
Abinopharm Reports Positive Clinical Trial Outcomes for Oral Dr.Ergo® L-Ergothioneine in Enhancing Skin Health

Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to announce that its partner, EG...

July 07, 2025 | Monday | News
Ferring Pharmaceuticals Announces ESHRE Data Confirming Conventional FSH Dosing for Rekovelle® Matches Follitropin Alfa in IVF

Data presented today at the ESHRE congress builds evidence for conventional-based Follicular Stimulating Hormone (FSH) dosing for Rekovelle® (fol...

July 03, 2025 | Thursday | News
MaaT Pharma and Clinigen Sign Exclusive European Licensing Deal for Xervyteg® in Acute Graft-Versus-Host Disease

MaaT Pharma and Clinigen signed exclusive long-term licensing and distribution agreement and commercial supply agreement for Xervyteg® (MaaT013),...

July 03, 2025 | Thursday | News
ReproNovo Doses First Participant in Phase 2 Trial of RPN-001, a Novel Oral Therapy for Male Infertility

RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosterone No FDA-...

July 02, 2025 | Wednesday | News
Claritev Partners with Fractional AI to Accelerate Responsible GenAI Adoption in Healthcare

Fractional AI, a leading provider of bespoke generative AI solutions, announced a new collaboration with Claritev, formerly known as MultiPlan. This coll...

June 26, 2025 | Thursday | News
Nu Skin Revamps ageLOC® Tru Face® Line with Refillable, Eco-Conscious Packaging

Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness company, is breathing new life into its iconic ageLOC® Tru Face® line with a r...

June 26, 2025 | Thursday | News
Novadip Biosciences Secures FDA RMAT Designation for NVD003 in Rare Pediatric Bone Disorder

Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, announces that the FDA has granted the Regenerative...

June 24, 2025 | Tuesday | News
Alvotech and Advanz Pharma Receive CHMP Positive Opinion for AVT06, a Proposed Biosimilar to Eylea®

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

June 24, 2025 | Tuesday | News
Nutriband and Kindeva Complete Commercial Manufacturing Scale-Up for AVERSA™ Fentanyl, Advancing World’s First Abuse-Deterrent Opioid Patch

Nutriband Inc.  a company engaged in the development of prescription transdermal pharmaceutical products, announced that it has completed commercial...

June 24, 2025 | Tuesday | News
Yale School of Medicine Launches Biomedical Imaging Institute to Drive Innovation in Health and Disease Research

Yale School of Medicine (YSM) announces the launch of the Yale Biomedical Imaging Institute, a cross-disciplinary hub that will unite leading experts in ...

June 23, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close